Article

Selecting Topical and Systemic Agents for Recurrent Aphthous Stomatitis (See Letter to the Editor. 2002;70:275.)

Recurrent aphthous stomatitis (RAS) is one of the most common oral diseases worldwide. Although the exact etiology of RAS remains unknown, a variety of topical and systemic preparations may be used for palliation or prevention. In most patients with RAS, topical agents, including over-the-counter preparations such as amlexanox, prescribed corticosteroids, or antimicrobial agents, are sufficient to control the disease. Patients with frequent exacerbations or those with a severe form of RAS that is unresponsive to topical treatments often require systemic agents to control their disease. These include corticosteroids, colchicine, dapsone, pentoxifylline, and thalidomide. All therapies are palliative, and none result in permanent remission.


 

Recommended Reading

Dermatology Secrets in Color, Second Edition [book review]
MDedge Dermatology
Primary Multiple Miliary Osteoma Cutis and Exogenous Ochronosis
MDedge Dermatology
Neutrophilic Eccrine Hidradenitis in a Patient With Behçet's Disease
MDedge Dermatology
The Ocular Manifestations of Rosacea
MDedge Dermatology
Concurrent Herpes Simplex Type 1 and Varicella-Zoster in the V2 Dermatome in an Immunocompetent Patient
MDedge Dermatology
Becker's Nevus Syndrome
MDedge Dermatology
Infantile Acute Hemorrhagic Edema of the Skin
MDedge Dermatology
Tretinoin Cream 0.02% for the Treatment of Photodamaged Facial Skin: A Review of 2 Double-Blind Clinical Studies
MDedge Dermatology
What's Eating You? Demodex folliculorum
MDedge Dermatology
Dermatologic Surgery Into the Next Millennium, Part II
MDedge Dermatology